Activation of TrkB with TAM-163 Results in Opposite Effects on Body Weight in Rodents and Non-Human Primates
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Strong genetic data link the Tyrosine kinase receptor B (TrkB) and its major endogenous ligand brain-derived neurotrophic factor (BDNF) to the regulation of energy homeostasis, with loss-of-function mutations in either gene causing severe obesity in both mice and humans. It has previously been reported that peripheral administration of the endogenous TrkB agonist ligand neurotrophin-4 (NT-4) profoundly decreases food intake and body weight in rodents, while paradoxically increasing these same parameters in monkeys. We generated a humanized TrkB agonist antibody, TAM-163, and characterized its therapeutic potential in several models of type 2 diabetes and obesity. In vitro, TAM-163 bound to human and rodent TrkB with high affinity, activated all aspects of the TrkB signaling cascade and induced TrkB internalization and degradation in a manner similar to BDNF. In vivo, peripheral administration of TAM-163 decreased food intake and/or body weight in mice, rats, hamsters, and dogs, but increased food intake and body weight in monkeys. The magnitude of weight change was similar in rodents and non-human primates, occurred at doses where there was no appreciable penetration into deep structures of the brain, and could not be explained by differences in exposures between species. Rather, peripherally administered TAM-163 localized to areas in the hypothalamus and the brain stem located outside the blood-brain barrier in a similar manner between rodents and non-human primates, suggesting differences in neuroanatomy across species. Our data demonstrate that a TrkB agonist antibody, administered peripherally, causes species-dependent effects on body weight similar to the endogenous TrkB ligand NT-4. The possible clinical utility of TrkB agonism in treating weight regulatory disorder, such as obesity or cachexia, will require evaluation in man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TAM-163, an antibody targeting TrkB, has been shown to be a partial TrkB agonist but only tested as an agonist agent for body weight regulatory disorders (Perreault et al. 2013).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Perreault et al. 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896
Rios, M., Fan, G., Fekete, C., Kelly, J., Bates, B., Kuehn, R., Lechan, R. M., & Jaenisch, R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.10.1748 · Cited by 780
A de novo mutation affecting human TrkB associated with severe obesity and developmental delay
Yeo, G. S. H., Connie Hung, C.-C., Rochford, J., Keogh, J., Gray, J., Sivaramakrishnan, S., O'Rahilly, S., & Farooqi, I. S. (2004) · Nature Neuroscience · doi:10.1038/nn1336 · Cited by 607
Gray, J., Yeo, G. S. H., Cox, J. J., Morton, J., Adlam, A.-L. R., Keogh, J. M., Yanovski, J. A., El Gharbawy, A., Han, J. C., Tung, Y. C. L., et al. (2006) · Diabetes · doi:10.2337/db06-0550 · Cited by 515
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 451
Unger, T. J., Calderon, G. A., Bradley, L. C., Sena-Esteves, M., & Rios, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3308-07.2007 · Cited by 374
Self-citationBrain-Derived Neurotrophic Factor and Obesity in the WAGR Syndrome
Han, J. C., Liu, Q.-R., Jones, M., Levinn, R. L., Menzie, C. M., Jefferson-George, K. S., Adler-Wailes, D. C., Sanford, E. L., Lacbawan, F. L., Uhl, G. R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801119 · Cited by 352
Clinical relevance of the neurotrophins and their receptors
Allen, S. J., & Dawbarn, D. (2006) · Clinical Science · doi:10.1042/cs20050161 · Cited by 320
Circumventricular Organs: Definition and Role in the Regulation of Endocrine and Autonomic Function
Ganong, W. F. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03259.x · Cited by 307 · cited 4×
“However, specialized regions of the CNS positioned near the ventricular system and called circumventricular organs (CVOs) contain fenestrated endothelia rather than tight junctions and allow access of large molecules to structures, including the median eminence located near the arcuate nucleus (ARC) of the HT and the…”
BackgroundInfluentialCellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues.
Shibayama, E., & Koizumi, H. (1996) · Europe PMC (PubMed Central) · Cited by 289
Brain-derived neurotrophic factor (BDNF) and food intake regulation: A minireview
Lebrun, B., Bariohay, B., Moyse, E., & Jean, A. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.02.027 · Cited by 219
Zheng, J., Shen, W.-H., Lu, T.-J., Zhou, Y., Chen, Q., Wang, Z., Xiang, T., Zhu, Y.-C., Zhang, C., Duan, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709930200 · Cited by 140
Brain‐derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice
Nakagawa, T., Ono‐Kishino, M., Sugaru, E., Yamanaka, M., Taiji, M., & Noguchi, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.290 · Cited by 130
Wellmer, A., Misra, V. P., Sharief, M. K., Kopelman, P. G., & Anand, P. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01019.x · Cited by 111
Nakagawa, T., Ogawa, Y., Ebihara, K., Yamanaka, M., Tsuchida, A., Taiji, M., Noguchi, H., & Nakao, K. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802265 · Cited by 109
Expression of trk receptors in the developing and adult human central and peripheral nervous system
Muragaki, Y., Timothy, N., Leight, S., Hempstead, B. L., Chao, M. V., Trojanowski, J. Q., & Lee, V. M. ‐. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903560306 · Cited by 105
A Novel Endocytic Recycling Signal Distinguishes Biological Responses of Trk Neurotrophin Receptors
Chen, Z.-Y., Ieraci, A., Tanowitz, M., & Lee, F. S. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0651 · Cited by 98
Sun, H. D., Malabunga, M., Tonra, J. R., DiRenzo, R., Carrick, F. E., Zheng, H., Berthoud, H.-R., McGuinness, O. P., Shen, J., Bohlen, P., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2006 · Cited by 95
Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reduces energy intake
Wang, C., Bomberg, E., Billington, C., Levine, A., & Kotz, C. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00011.2007 · Cited by 90
TrkB Agonists Ameliorate Obesity and Associated Metabolic Conditions in Mice
Tsao, D., Thomsen, H. K., Chou, J., Stratton, J., Hagen, M., Loo, C., Garcia, C., Sloane, D. L., Rosenthal, A., & Lin, J. C. (2008) · Endocrinology · doi:10.1210/en.2007-1166 · Cited by 83
Qian, M. D., Zhang, J., Tan, X.-Y., Wood, A., Gill, D., & Cho, S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1118-06.2006 · Cited by 67 · cited 4×
“TAM-163 is a humanized derivative of 29D7 [18] containing the human IgG1 heavy chain and the human kappa light chain.”
BackgroundMethodInfluentialMenyhért, J., Wittmann, G., Lechan, R. M., Keller, E., Liposits, Z., & Fekete, C. (2007) · Endocrinology · doi:10.1210/en.2007-0390 · Cited by 62
Lin, J. C., Tsao, D., Barras, P., Bastarrachea, R. A., Boyd, B., Chou, J., Rosete, R., Long, H., Forgie, A., Abdiche, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001900 · Cited by 57
Vugmeyster, Y., DeFranco, D., Szklut, P., Wang, Q. L., & Xu, X. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21855 · Cited by 53
Self-citationGrove, K. L., Chen, P., Koegler, F. H., Schiffmaker, A., Smith, M. S., & Cameron, J. L. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00093-7 · Cited by 46
Picha, K. M., Cunningham, M. R., Drucker, D. J., Mathur, A. S., Ort, T., Scully, M. S., Soderman, A. R., Spinka-Doms, T., Stojanovic-Susulic, V., Thomas, B. A., et al. (2008) · Diabetes · doi:10.2337/db07-1775 · Cited by 41
Zhang, J., Chen, D., Gong, X., Ling, H., Zhang, G., Wood, A., Heinrich, J. N., & Cho, S. (2006) · Neurosignals · doi:10.1159/000094385 · Cited by 10
Cited by
The Hunger Genes: Pathways to Obesity
van der Klaauw, A. A., & Farooqi, I. S. (2015) · Cell · doi:10.1016/j.cell.2015.03.008 · Cited by 393
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities
Liu, W., Wang, X., O’Connor, M., Wang, G., & Han, F. (2020) · Neural Plasticity · doi:10.1155/2020/1969482 · Cited by 160
Qin, X., Zhao, Y., Zhang, T., Yin, C., Qiao, J., Guo, W., & Lu, B. (2022) · Nature Communications · doi:10.1038/s41467-022-28611-2 · Cited by 144
A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology
Wie, J., Liu, Z., Song, H., Tropea, T. F., Yang, L., Wang, H., Liang, Y., Cang, C., Aranda, K., Lohmann, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03185-z · Cited by 120
Metadata
- Authors
- Perreault, M., Feng, G., Will, S., Gareski, T., Kubasiak, D., Marquette, K., Vugmeyster, Y., Unger, T. J., Jones, J., Qadri, A., Hahm, S., Sun, Y., Rohde, C. M., Zwijnenberg, R., Paulsen, J., & Gimeno, R. E.
- Affiliations
- Pfizer (United States) (US)
- Corresponding author
- Perreault, Mylène
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-20
- Volume
- 8
- Issue
- 5
- Pages
- e62616
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3659094
- OpenAlex
- W2055083670
- Cited by
- 26
- References
- 28
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 3 · 2015: 3 · 2014: 1 · 2013: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TrkB, neurotrophin-4, brain-derived neurotrophic factor, body weight regulation, dietary intake, species differences, obesity, type 2 diabetes, hypothalamus, brainstem, blood-brain barrier, cachexia, energy homeostasis, neuroanatomy
- MeSH terms
- Animals, Antibodies, Monoclonal, Appetite Depressants, Body Weight, Energy Intake, Dogs, Drug Evaluation, Preclinical, Female, Cricetinae, Humans, Hypothalamus, Macaca fascicularis, Macaca mulatta, Male, Mesocricetus, Mice, Inbred C57BL, Obesity, Rats, Zucker, Tissue Distribution, Rats, Sprague-Dawley, Receptor, trkB, Mice, Rats, HEK293 Cells, Diet, High-Fat, Administration, Intravenous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.